Novo Nordisk Limited

Broadfield Park, Brighton Road, Crawley, West Sussex, RH11 9RT
Telephone: +44 (0)1293 613555
Fax: +44 (0)1293 613535
Medical Information Direct Line: +44 (0)845 600 5055
Medical Information e-mail: ukmedicalinfo@novonordisk.com
Customer Care direct line: +44 (0)845 600 5055
Medical Information Fax: +44 (0)1293 613211

Patient Information Leaflet last updated on the eMC: 05/08/2011
PIL Insulatard InnoLet

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 16/02/2010 and displayed until 05/08/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
  • Transfer to upgraded management system
Updated on 05/11/2007 and displayed until 16/02/2010
Reasons for adding or updating:
  • Change to side-effects
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to storage instructions
Updated on 28/07/2003 and displayed until 05/11/2007
Reasons for adding or updating:
  • Update to PIL
Updated on 18/09/2001 and displayed until 28/07/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   human insulin